iShares U.S. Pharmaceuticals ETF IHE
Set alert
107.61 USD +0.69 +0.65%
As of Nov 3, 11:59 AM ET
106.67 Day range 108.19
75.03 52-week range 109.43
- YTD
- +26.85%
- 1 year
- +40.96%
- Open
- 106.40
- Prev close
- 106.92
- Mkt cap
- 1.21B
- Vol
- 87.78K
- Avg vol
- 231.72K
- EPS
- 3.82
- P/E
- 28.21
- Div yield
- 0.00%
More statistics
- Low
- 106.67
- High
- 108.19
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 102.41
- 200-d avg
- 94.76
2Y chart
Events in this range
- Dec 17, 2024Dividend: 0.21082
- Mar 18, 2025Dividend: 0.29167
- Jun 16, 2025Dividend: 0.30654
- Sep 16, 2025Dividend: 0.3124
- Dec 16, 2025Dividend: 0.58525
- Mar 17, 2026Dividend: 0.28449
- Jun 15, 2026Dividend: 0.28478
- Sep 15, 2026Dividend: 0.27888
Signals (86)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
Newest 20 of 86.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.98
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 102.41
- 200-day average
- 94.76
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
News
- Alphabet Sinks 11.8%, Small Caps Rally on Strong GDP Growth: Stock Market Today
- Capital Investment Advisors LLC Makes New $630,000 Investment in iShares U.S. Pharmaceuticals ETF $IHE
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- From Laggard to Leader: The Surprising Comeback of Healthcare
- Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?
- Better Pharma ETF: iShares IHE vs. State Street XPH
- Execution of Pharma Tariffs Brings These ETFs Into Focus
- Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
- IHE: Innovation Supports The Outlook, Valuation Limits Conviction
- IHE: Large-Cap Pharma Cools After A Hot Summer
Your note
Sign in to keep a note on IHE — it syncs with the Stock Master app.